Black Bird Biotech, Inc. BBBT OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

14/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Black Bird Biotech, Inc. (BBBT) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 13/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

14/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

0/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — BBBT

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.40

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.01

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$0.00	$0.00	$-89.99K	-
2014	$0.00	$0.00	$-99.52K	-
2015	$0.00	$0.00	$-112.47K	-
2016	$0.00	$0.00	$-106.27K	-
2017	$0.00	$0.00	$-110.01K	-
2018	$0.00	$0.00	$-121.11K	-
2019	$0.00	$17.77K	$-163.63K	-920.8%
2020	$-0.01	$57.6K	$-691.57K	-1200.6%
2021	$-0.01	$104.46K	$-2.1M	-2007.2%
2022	$-0.01	$82.56K	$-1.66M	-2009.1%